SCHEMBL4817067

SCHEMBL4817067

Fc1ccccc1N1CCN(Cc2cc3ncccc3o2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.52
▸ ALDH1A1 P00352 4/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ SLC2A1 P11166 1/20 0.52
▸ HTR1A P08908 1/20 0.51
▸ HTR2A P28223 1/20 0.51
▸ HTR7 P34969 1/20 0.51
▸ POLB P06746 2/20 0.50
▸ TSHR P16473 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ DRD4 P21917 3/20 0.49
▸ DRD3 P35462 3/20 0.48
▸ HSD17B10 Q99714 1/20 0.47
▸ GRM2 Q14416 1/20 0.46
▸ CASP1 P29466 1/20 0.45
▸ CASP7 P55210 1/20 0.45
▸ MAPT P10636 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ DRD2 P14416 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7106423 0.94 HTR1A (0.48) KDM4EALDH1A1TDP1SLC2A1HTR1A
SCHEMBL4818594 0.84 DRD4 (0.51) HTR1AHTR2AHTR7DRD4DRD2
SCHEMBL4824115 0.83 ALDH1A1 (0.57) KDM4EALDH1A1TDP1HTR1AHTR2A
SCHEMBL4823372 0.83 KDM4E (0.52) KDM4EALDH1A1HTR1ALMNADRD4
SCHEMBL4823578 0.82 DRD4 (0.52) KDM4EALDH1A1TDP1TSHRLMNA
SCHEMBL3398854 0.78 SIGMAR1 (0.66) KDM4EALDH1A1POLBTSHRLMNA
SCHEMBL4825079 0.78 PARP1 (0.42) HTR1ADRD4
SCHEMBL4825010 0.78 DRD4 (0.48) KDM4EALDH1A1TDP1HTR1ALMNA
SCHEMBL4820489 0.76 HTR2B (0.39) HTR1ADRD4DRD2
SCHEMBL4819167 0.75 DRD4 (0.57) KDM4EALDH1A1TDP1HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7470691-B2 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction ABBOTT LABORATORIES (US) 2008-12-30 — — US claimed
US-20070265249-A1 Fused Bicyclic Aromatic Compounds that are Useful in Treating Sexual Dysfunction ABBVIE INC. 2007-11-15 — — US claimed
US-20060172995-A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction ABBVIE INC. 2006-08-03 — — US claimed
US-7057042-B2 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction ABBOTT LABORATORIES (US) 2006-06-06 — — US claimed
US-20040063713-A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction ABBVIE INC. 2004-04-01 — — US claimed
US-20040002488-A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction WEINSTOCK, STEVEN F. 2004-01-01 — — US claimed
US-7470691-B2 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction ABBOTT LABORATORIES (US) 2008-12-30 — — US disclosed
US-20070265249-A1 Fused Bicyclic Aromatic Compounds that are Useful in Treating Sexual Dysfunction ABBVIE INC. 2007-11-15 — — US disclosed
US-7235661-B2 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction ABBOTT LABORATORIES (US) 2007-06-26 — — US disclosed
US-20060172995-A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction ABBVIE INC. 2006-08-03 — — US disclosed
US-7057042-B2 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction ABBOTT LABORATORIES (US) 2006-06-06 — — US disclosed
US-20040063713-A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction ABBVIE INC. 2004-04-01 — — US disclosed
US-20040002488-A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction WEINSTOCK, STEVEN F. 2004-01-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063713-A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction CYP19A1, CYP17A1, HSD17B11 KDM4E 3657/4885ALDH1A1 246/4885TDP1 963/4885
US-20070265249-A1 Fused Bicyclic Aromatic Compounds that are Useful in Treating Sexual Dysfunction CYP19A1, CYP17A1, HSD17B11 KDM4E 2778/4885ALDH1A1 91/4885TDP1 996/4885
US-20060172995-A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction CYP19A1, CYP17A1, DDC KDM4E 2026/4885ALDH1A1 206/4885TDP1 1426/4885
US-20040002488-A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction CYP19A1, CYP17A1, HSD17B11 KDM4E 3657/4885ALDH1A1 246/4885TDP1 963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback